Ranked API manufacturers
Credentials confirmed against the regulator files on 25 July 2026
Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 12 markets.
Last FDA inspection
2023 · VAI
GMP recognised in
12 markets
Credentials confirmed against the regulator files on 25 July 2026
Its 2015 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Last FDA inspection
2015 · VAI
GMP recognised in
2 markets
03 Vietnam
Makes the APIFinished dose
Registered with DAV (Vietnam) for cefalotin. Its GMP is recognised in 1 market.
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile 04 Vietnam
Makes the APIFinished dose
Registered with DAV (Vietnam) for cefalotin. Its GMP is recognised in 2 markets.
Last FDA inspection
Not established
GMP recognised in
2 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile 05 Vietnam
Makes the APIFinished dose
Registered with DAV (Vietnam) for cefalotin. Its GMP is recognised in 1 market.
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile 2 more manufacturers hold filings for cefalotin
The names are listed below. Ask Fred about the filings, inspection history and GMP
certificates on record for each manufacturer.
Chat with Fred, your AI analyst Contract manufacturers (1)
Contract manufacturers make to order rather than holding their own filing for this
molecule.
Finished-dose makers (28)
How this list is built
The order is set by active filings weighted by regulator, inspection outcomes and their
recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags.
Every factor appears on the card it produced.
Read the full method.
- Active US DMFs
- FDA, List of Drug Master Files
- Valid CEPs
- EDQM certificate database
- Inspection outcomes
- FDA inspection classifications
- GMP certificates
- EudraGMDP and national regulators